Sonic Healthcare Limited (ASX:SHL) has inked a deal to buy the New South Wales, Queensland and Western Australian pathology businesses of Healthscope for $100 million.
The pathology and radiology provider says the assets have combined annualised revenue of $105 million.
The purchase will be paid for through Sonic’s existing debt facilities and subject to regulatory approvals is expected to be finalised by August.
Sonic’s chief says the acquisitions will be value accretive for the company’s shareholders.
Sonic Healthcare boosted its first half net profit by 8 per cent to $143 million.
